Novozymes A/S
CSE:NSIS B
Novozymes A/S
CSE:NSIS B
Price:
395
DKK
1.99%
Market Cap:
kr163.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novozymes A/S
CSE:NSIS B
|
DK |
|
Invictus Energy Ltd
ASX:IVZ
|
AU |
|
H
|
Hao Tian International Construction Investment Group Ltd
HKEX:1341
|
HK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of NSIS B.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NSIS B
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
NSIS B Competitors Multiples
Novozymes A/S Competitors
Novozymes A/S Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DK |
|
Novozymes A/S
CSE:NSIS B
|
165.6B DKK | 9.3 | 54.8 | 28.9 | 37.9 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
77.8B USD | 3.3 | 30.3 | 19.7 | 23.2 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.1T JPY | 4.7 | 25 | 12.2 | 16.9 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
74B USD | 4.6 | 35.6 | 20.8 | 27.8 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 1 | 10.5 | 5.8 | 7.1 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
270.1B CNY | 1.5 | 24.3 | 21 | 21 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
24.9B CHF | 3.5 | 24.2 | 16.9 | 21.5 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.6 | 17.5 | 10.3 | 14.2 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
22.8B USD | 1.4 | 14.5 | 10.1 | 12.6 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.1T INR | 6.3 | 56.8 | 34.1 | 41.8 | |
| US |
|
Albemarle Corp
NYSE:ALB
|
20.4B USD | 4 | -30.2 | 29.6 | 265.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
